skip to main content
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Products

Show More

Show More

68 Total results for product and free and sample content found

Scrip

Scrip Asks...What Does 2020 Hold For Biopharma? Part 1: Therapeutic Advances

By Eleanor Malone 20 Oct 2022

Scrip_Asks_What_Does_2020_Hold_1

Advances in multiple scientific areas will mature into novel therapeutics, often tailored for the individual patient and increasingly curative, making biopharma an exciting place to be in 2020.

Topic Innovation Market Intelligence Research & Development

Pharmaprojects

Informa Pharma Intelligence Launches 30th Edition Pharma R&D Annual Review

24 Mar 2022

Informa Pharma Intelligence Launches 30th Edition Pharma R&D Annual Review

Pharmaprojects’ 2022 Report Highlights Breakthrough Trends in Pharmaceutical R&D

Topic Research & Development

Scrip

Quick Listen: Scrip's Five Must-Know Things

By Ian Haydock 08 Dec 2020

Scrip August Podcast

Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things

Topic Coronavirus Vaccines Research & Development

HBW Insight

UK Researchers Seek Commercial Partner For Nasal Spray Shown To 'Prevent' COVID-19

By Tom Gallen 29 Nov 2020

covid19 nasal spray R&D

A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.

Topic Coronavirus Research & Development Vaccines OTC Drugs

Scrip

Quick Listen: Scrip's Five Must-Know Things

By Ian Haydock 29 Nov 2020

Scrip August Podcast

Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things

Topic Coronavirus Research & Development Vaccines

Scrip

Coronavirus Update: Roche's Actemra Fails In Phase III COVID Study

27 Nov 2020

Coronavirus Update Roche's Actemra Fails In Phase III COVID Study

Disappointment as Roche/Chugai antibody tocilizumab misses most endpoints. 

Topic Coronavirus Clinical Trials Research & Development

Scrip

Coronavirus Update: After Rumors Of Shortcut To Market, AZ Pledges To 'Follow Science' In Vaccine Trials

By Scrip Team 27 Nov 2020

Covid19 mandatory face coverings

The company reiterates core values to 'follow the science' and 'put patients first' after talk of an emergency use authorization without completing Phase III trials.

Topic Coronavirus Clinical Trials Research & Development

Breast Cancer Clinical Landscape and Recent Trends Whitepaper

27 Nov 2020

White paper

Get a deeper understanding of breast cancer clinical trials initiated since 2014 and what the trends have meant for strategies in this area, with this free whitepaper from Citeline.

Topic Cancer Clinical Trials Research & Development

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: